triumph-1 trial retatrutide The data just dropped โ and is rewriting what's possible in obesity medicine. ๐งฌ just released Phase 3 results, and the numbers are unlike anything we've seen from a medication Retatrutide Delivers Bariatric-Level Weight Loss
Description
Tirzepatide is a dual GIP/GLP-1 agonist that targets two incretin receptors simultaneously, producing more pronounced metabolic effects
Clinical Trials: The Primary Access Route Enrolling in a TRIUMPH trial is the only way to receive pharmaceutical-grade retatrutide under medical supervision
*Peptide Disclaimer: Some peptides are not approved by the U.S
We personalize your GLP1 dose, nutrition, and movement
Foundayo can be taken at any time of day without food or water restrictions
Highlights of Prescribing Information: Mounjaro (tirzepatide) injection, for subcutaneous use
